Article info
PDFTherapeutics/Prevention
Randomised controlled trial
Although the evidence is not clear, decreases in prostate cancer mortality in specific subgroups of men may be due to screening
- Correspondence to : Associate Professor Dragan Ilic, Monash University, Level 6, 99 Commercial Rd, Melbourne, VIC 3004, Australia; dragan.ilic{at}monash.edu
Citation
Although the evidence is not clear, decreases in prostate cancer mortality in specific subgroups of men may be due to screening
Publication history
- First published March 13, 2015.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions